Seung‐Hoon Beom

1.7k total citations
69 papers, 901 citations indexed

About

Seung‐Hoon Beom is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Seung‐Hoon Beom has authored 69 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 15 papers in Surgery. Recurrent topics in Seung‐Hoon Beom's work include Colorectal Cancer Treatments and Studies (22 papers), Gastric Cancer Management and Outcomes (15 papers) and Colorectal and Anal Carcinomas (9 papers). Seung‐Hoon Beom is often cited by papers focused on Colorectal Cancer Treatments and Studies (22 papers), Gastric Cancer Management and Outcomes (15 papers) and Colorectal and Anal Carcinomas (9 papers). Seung‐Hoon Beom collaborates with scholars based in South Korea, United States and China. Seung‐Hoon Beom's co-authors include Minkyu Jung, Joong Bae Ahn, Sang Joon Shin, Sun Young Rha, Hyo Song Kim, Jee Hung Kim, Hyun Cheol Chung, Su Jin Heo, Nam Kyu Kim and Chang Gon Kim and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Seung‐Hoon Beom

65 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seung‐Hoon Beom South Korea 17 459 361 230 150 150 69 901
Martin Maus Germany 12 481 1.0× 410 1.1× 285 1.2× 137 0.9× 192 1.3× 32 838
Antonia Strippoli Italy 17 532 1.2× 438 1.2× 328 1.4× 134 0.9× 111 0.7× 66 1.1k
Pengfei Kong China 19 678 1.5× 381 1.1× 276 1.2× 174 1.2× 142 0.9× 41 1.1k
Byoung Yong Shim South Korea 18 596 1.3× 359 1.0× 248 1.1× 232 1.5× 101 0.7× 110 1.0k
Maria Ignez Braghiroli Brazil 14 583 1.3× 302 0.8× 230 1.0× 210 1.4× 162 1.1× 58 901
Shinya Tokunaga Japan 15 659 1.4× 590 1.6× 368 1.6× 162 1.1× 121 0.8× 65 1.1k
Mehmet Akce United States 16 847 1.8× 255 0.7× 275 1.2× 187 1.2× 193 1.3× 115 1.2k
Kohei Shigeta Japan 15 590 1.3× 210 0.6× 260 1.1× 139 0.9× 83 0.6× 75 945
Wenzhuo He China 19 878 1.9× 279 0.8× 296 1.3× 241 1.6× 184 1.2× 84 1.3k
Keisuke Aiba Japan 15 500 1.1× 284 0.8× 333 1.4× 194 1.3× 149 1.0× 71 992

Countries citing papers authored by Seung‐Hoon Beom

Since Specialization
Citations

This map shows the geographic impact of Seung‐Hoon Beom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seung‐Hoon Beom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seung‐Hoon Beom more than expected).

Fields of papers citing papers by Seung‐Hoon Beom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seung‐Hoon Beom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seung‐Hoon Beom. The network helps show where Seung‐Hoon Beom may publish in the future.

Co-authorship network of co-authors of Seung‐Hoon Beom

This figure shows the co-authorship network connecting the top 25 collaborators of Seung‐Hoon Beom. A scholar is included among the top collaborators of Seung‐Hoon Beom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seung‐Hoon Beom. Seung‐Hoon Beom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Changhee, Seung‐Hoon Beom, Minsun Jung, et al.. (2025). An open-label, phase IB/II study of abemaciclib with paclitaxel for tumors with CDK4/6 pathway genomic alterations. ESMO Open. 10(2). 104106–104106.
2.
Choi, Seo Hee, Seung‐Hoon Beom, Young Deuk Choi, et al.. (2024). The Role of Local Prostate and Metastasis-Directed Radiotherapy in the Treatment of Oligometastatic Prostate Cancer. Cancers. 16(18). 3159–3159.
3.
Kim, Hyunwook, Jeong Eun Choi, Han Sang Kim, et al.. (2024). A rapid assessment tool for systemic treatment outcomes in colorectal cancer with deep bidirectional transformers.. Journal of Clinical Oncology. 42(16_suppl). e15567–e15567. 1 indexed citations
4.
Ahn, Jin‐Hee, Jeeyun Lee, Changhee Park, et al.. (2024). Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II Study. Clinical Cancer Research. 30(8). 1457–1465. 13 indexed citations
6.
Kwon, Jung Hye, Seung‐Hoon Beom, Sang Joon Shin, et al.. (2023). Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea. SHILAP Revista de lepidopterología. 4(1). 9–16. 1 indexed citations
7.
Lee, Keun‐Wook, Sae‐Won Han, Tae Won Kim, et al.. (2023). A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer. Cancer Research and Treatment. 56(2). 590–601. 1 indexed citations
8.
Lyu, Chuhl Joo, Jung Woo Han, Seung Min Hahn, et al.. (2022). Care Needs of Adolescents and Young Adults with Cancer Undergoing Active Treatment in South Korea: A Mixed Methods Study. Journal of Adolescent and Young Adult Oncology. 12(3). 398–407. 5 indexed citations
9.
Lee, Jeongshim, Woong Sub Koom, Hwa Kyung Byun, et al.. (2021). Metastasis-Directed Radiotherapy for Oligoprogressive or Oligopersistent Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 21(2). e78–e86. 9 indexed citations
10.
Park, Kyung Hee, Jongsun Lee, Seung‐Hoon Beom, et al.. (2021). Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection. World Allergy Organization Journal. 14(7). 100553–100553. 9 indexed citations
11.
Lee, Keun‐Wook, Sang‐Hee Cho, Tae Won Kim, et al.. (2020). A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases. Clinical Colorectal Cancer. 19(3). e140–e150. 15 indexed citations
12.
Park, Ji Soo, Beodeul Kang, Yehyun Park, et al.. (2019). Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors. Journal of Cancer Prevention. 24(1). 48–53. 2 indexed citations
13.
Park, Hyung Soon, Woo Sun Kwon, Sejung Park, et al.. (2019). Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer. Journal for ImmunoTherapy of Cancer. 7(1). 268–268. 28 indexed citations
14.
Kim, Min Hwan, Xianglan Zhang, Minkyu Jung, et al.. (2018). Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial. Cancer Research and Treatment. 51(2). 819–831. 15 indexed citations
15.
Kim, Chan, Woo Ram Kim, Ki‐Yeol Kim, et al.. (2018). Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection. Clinical Colorectal Cancer. 17(3). e513–e518. 31 indexed citations
16.
Park, Hyung Soon, Hyo Song Kim, Seung‐Hoon Beom, et al.. (2018). Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial. Annals of Surgical Oncology. 25(11). 3222–3230. 76 indexed citations
17.
Beom, Seung‐Hoon, Jisu Oh, Tae‐Yong Kim, et al.. (2016). Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea. Cancer Research and Treatment. 49(2). 454–463. 2 indexed citations
18.
Kim, Chang Gon, Joong Bae Ahn, Minkyu Jung, et al.. (2016). Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer. Annals of Surgical Oncology. 24(1). 227–235. 42 indexed citations
19.
Park, Hyun Jung, Seung‐Hyun Kim, KH Park, et al.. (2016). A New Practical Desensitization Protocol for Oxaliplatin-Induced Immediate Hypersensitivity Reactions: A Necessary and Useful Approach. Journal of Investigational Allergology and Clinical Immunology. 26(3). 168–176. 18 indexed citations
20.
Park, Hyung Soon, Minkyu Jung, Sang Joon Shin, et al.. (2015). Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer. Annals of Surgical Oncology. 23(3). 928–935. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026